The decision to continue or discontinue Zepbound should weigh the benefits of weight loss against any mental health concerns, with patient safety and well-being as the primary consideration
Research has shown that the weight-reducing effects of pramlintide are additive to those of GLP-1 receptor agonists, suggesting non-overlapping satiety mechanisms that have informed the development of next-generation dual amylin/GLP-1 receptor agonist combinations
Peptides can modulate biological pathways that may be difficult to target with small molecules
GLP-1 is an endogenous incretin peptide secreted from intestinal L-cells after food intake, exerting glucose-dependent hypoglycemic regulation without triggering hypoglycemia risk under normal low-sugar status
The aim of this article was to critically review the available evidence for an impact of glucose uptake, energy utilization, and inflammation on the pathophysiology of AD and PD
For example, andrographolide exhibits multi-organ toxicity in multiple studies
